1. Home
  2. NBY vs SOPH Comparison

NBY vs SOPH Comparison

Compare NBY & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$15.78

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.28

Market Cap

330.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
SOPH
Founded
2000
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
330.4M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
NBY
SOPH
Price
$15.78
$5.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
3.2M
89.9K
Earning Date
11-07-2025
03-03-2026
Dividend Yield
6.30%
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$10,302,000.00
$73,297,000.00
Revenue This Year
$23.91
$18.32
Revenue Next Year
$32.05
$15.61
P/E Ratio
$493.09
N/A
Revenue Growth
390.34
13.66
52 Week Low
$0.46
$2.58
52 Week High
$19.95
$5.55

Technical Indicators

Market Signals
Indicator
NBY
SOPH
Relative Strength Index (RSI) 69.49 62.35
Support Level $10.42 $5.04
Resistance Level $19.95 $5.55
Average True Range (ATR) 3.14 0.31
MACD 0.59 0.04
Stochastic Oscillator 73.24 71.55

Price Performance

Historical Comparison
NBY
SOPH

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: